Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative

被引:5
|
作者
Yuan, Yuan [1 ]
Pan, Kathy [2 ]
Mortimer, Joanne [1 ]
Chlebowski, Rowan T. [2 ]
Luo, Juhua [3 ]
Yan, Jessica E. [2 ]
Yost, Susan E. [1 ]
Kroenke, Candyce H. [4 ]
Adams-Campbell, Lucile [5 ]
Nassir, Rami [6 ]
Sun, Yangbo [7 ]
Shadyab, Aladdin H. [8 ]
Vitolins, Mara Z. [9 ]
Saquib, Nazmus [10 ]
Wild, Robert A. [11 ]
Manson, JoAnn E. [12 ]
Nelson, Rebecca A. [1 ]
机构
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd,Bldg 51, Duarte, CA 91010 USA
[2] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA
[3] Univ Indiana, Bloomington, IN USA
[4] Kaiser Permanente, Oakland, CA USA
[5] Georgetown Univ, Sch Med, Washington, DC USA
[6] Al Umm Qura Univ, Sch Med, Dept Pathol, Mecca, Saudi Arabia
[7] Univ Iowa, Iowa City, IA USA
[8] Univ Calif San Diego, La Jolla, CA 92093 USA
[9] Wake Forest Sch Med, Winston Salem, NC 27101 USA
[10] Sulaiman Al Rajhi Coll Med, Al Bukairiyah, Saudi Arabia
[11] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[12] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
metabolic syndrome; postmenopausal women; risk factors; triple-negative breast cancer; Women's Health Initiative;
D O I
10.1002/cncr.33407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Triple-negative breast cancer (TNBC) has a high recurrence risk and poor clinical outcomes. Associations between metabolic syndrome (MetS) risk components and mortality in postmenopausal women with TNBC were examined in the Women's Health Initiative. METHODS: Five hundred forty-four postmenopausal women were diagnosed with nonmetastatic TNBC. Baseline risk components included a high waist circumference (>= 88 cm), high blood pressure, hypercholesterolemia, and diabetes. Groups were categorized by the number of MetS risk components: none, 1 or 2, or 3 or 4. Hazard ratios (HRs) and 95% confidence intervals (CIs) across groups were computed with multivariable adjusted Cox models. Outcomes included breast cancer-specific mortality and breast cancer overall mortality (breast cancer followed by death from any cause). Variables in the multivariable model included age at TNBC diagnosis; race/ ethnicity; income; education; clinical/observational trial status; history of oral contraceptive, hormone, and/or statin use; cancer stage; and chemotherapy and/or radiation treatment status. RESULTS: Of the 544 participants with TNBC, 33% had no MetS risk components (n = 178), 59% had 1 or 2 risk components (n = 323), and 8% had 3 or 4 risk components (n = 43). After a median follow-up from diagnosis of 8.3 years, multivariable results showed that women with 3 or 4 risk components had a nonsignificantly higher risk of breast cancer mortality (HR, 2.05; 95% CI, 0.94-4.47 trend P =.114) and a significantly higher risk of overall mortality (HR, 2.13; 95% CI, 1.22-3.71; trend P =.006) versus women with 0 risk components. CONCLUSIONS: Postmenopausal women with TNBC and 3 or 4 MetS risk components have a nonsignificantly higher breast cancer mortality risk and a significantly higher overall mortality risk, likely because of negative influences of metabolic risk factors on several causes of death.
引用
收藏
页码:1658 / 1667
页数:10
相关论文
共 50 条
  • [41] Rural-Urban Residence and Stage at Breast Cancer Diagnosis Among Postmenopausal Women: The Women's Health Initiative
    Sealy-Jefferson, Shawnita
    Roseland, Molly E.
    Cote, Michele L.
    Lehman, Amy
    Whitsel, Eric A.
    Mustafaa, Faheemah N.
    Booza, Jason
    Simon, Michael S.
    JOURNAL OF WOMENS HEALTH, 2019, 28 (02) : 276 - 283
  • [42] Metformin and breast cancer incidence in postmenopausal diabetic women in the Women's Health Initiative (WHI).
    Chlebowski, R. T.
    McTiernan, A.
    Aragaki, A. K.
    Rohan, T.
    Wactawski-Wende, J.
    Ipp, E.
    Euhus, D.
    Kaklamani, V. G.
    Vitolins, M.
    Wallace, R. B.
    Liu, S.
    Gunter, M. J.
    Phillips, L.
    Strickler, H.
    Howard, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study
    Pressler, Mary
    Rosenberg, Carol A.
    Derman, Benjamin A.
    Greenland, Philip
    Khandekar, Janardan
    Rodabough, Rebecca J.
    McTiernan, Anne
    Simon, Michael S.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (03) : 821 - 831
  • [44] Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women’s Health Initiative observational study
    Mary Pressler
    Carol A. Rosenberg
    Benjamin A. Derman
    Philip Greenland
    Janardan Khandekar
    Rebecca J. Rodabough
    Anne McTiernan
    Michael S. Simon
    Breast Cancer Research and Treatment, 2013, 139 : 821 - 831
  • [45] Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women
    Juhua Luo
    Candyce H. Kroenke
    Michael Hendryx
    Aladdin H. Shadyab
    Nianjun Liu
    Xiwei Chen
    Fengge Wang
    Fridtjof Thomas
    Nazmus Saquib
    Lihong Qi
    Ting-Yuan David Cheng
    Rhonda Arthur
    Jean Wactawski-Wende
    Breast Cancer Research and Treatment, 2021, 188 : 283 - 293
  • [46] Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women
    Luo, Juhua
    Kroenke, Candyce H.
    Hendryx, Michael
    Shadyab, Aladdin H.
    Liu, Nianjun
    Chen, Xiwei
    Wang, Fengge
    Thomas, Fridtjof
    Saquib, Nazmus
    Qi, Lihong
    Cheng, Ting-Yuan David
    Arthur, Rhonda
    Wactawski-Wende, Jean
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 283 - 293
  • [47] Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
    Davis, Andrew A.
    Kaklamani, Virginia G.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [48] Post-Stroke Cancer Risk among Postmenopausal Women: The Women's Health Initiative
    Sealy-Jefferson, Shawnita
    Cote, Michele L.
    Chlebowski, Rowan T.
    Rexrode, Kathryn M.
    Simon, Michael S.
    WOMENS HEALTH ISSUES, 2018, 28 (01) : 29 - 34
  • [49] Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study
    Royse, Kathryn E.
    El-Serag, Hashem B.
    Chen, Liang
    White, Donna L.
    Hale, Lauren
    Sangi-Haghpeykar, Haleh
    Jiao, Li
    JOURNAL OF WOMENS HEALTH, 2017, 26 (12) : 1270 - 1277
  • [50] Statins and breast cancer stage and mortality in the Women’s Health Initiative
    Pinkal Desai
    Amy Lehman
    Rowan T. Chlebowski
    Marilyn L. Kwan
    Monica Arun
    JoAnn E. Manson
    Sayeh Lavasani
    Sylvia Wasswertheil-Smoller
    Gloria E. Sarto
    Meryl LeBoff
    Jane Cauley
    Michele Cote
    Jennifer Beebe-Dimmer
    Allison Jay
    Michael S. Simon
    Cancer Causes & Control, 2015, 26 : 529 - 539